drugset / Trial / NCT00801463

Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis

NCT00801463

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the efficacy of prednisone and tripterygium wilfordii in treated Focal Segmental Glomerulosclerosis (FSGS).

Timeline

Start
2009-01
Primary completion
2011-01
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject tripterygium wilfordii Traditional medicine (herbal / TCM) 120 mg Oral